They assure the approval of the Sputnik V vaccine is imminent around the world

“They work and that’s what they tell us, now we have to wait for it to be like that “added the president of Richmond, producer of Sputnik V in Argentina.

Regarding the reasons why the WHO has not yet included the Sputnik V vaccine in its list of emergency use, the president of Laboratorios Richmond clarified that “there is an administrative problem, as said the doctors. Fernán Quirós and Carlos Regazzoni, leaders of the opposition, who clearly expressed this position ”.

>> Read more: Vizzotti announced that Sinopharm vaccine can be applied to children between 3 and 11 years old

In this regard, he added: “These are problems of information, of preparation of reports which may be different from one country to another, and they adapt ”.

“Of course, neither safety nor efficiency is at stake, has already been tested on hundreds of millions people ”, however specified Figueiras, who underlined that the inoculant of Russian origin is“ a vaccine so good, effective and sure that they provide it to practically half of the world ”.

On the other hand, Figueiras celebrated that in the Richmond laboratories they were reaching “The 10 million doses already very close, and nearly 5 million delivered” by Spoutnik V.

“Between yesterday and today, 1,600,000 doses of component 2 of the vaccine were delivered and we continue to work with all of our staff and scientists.”He detailed and stressed that Argentina has “a very good scientific basis and also in the field of clinical research, not only because of a cost issue, as one could say, but also because of the capacity of our doctors “.

Read more: Argentine government returned 1.3 million Sputnik V vaccines to Russia

Regarding the future of Sputnik V production in the country, the businessman assured that “It will depend on what is needed” and confirmed that the pharmaceutical company “makes the fund case to make it permanent”.

“Today, approval depends exclusively on the (Argentine) government contract. with the Russian government and depends on demand; this will vary depending on the vaccination plan, ”he said.

In this sense, he remarked: “We are already in a position to do 5 to 10 million vaccinations per month if needed, always depending on the arrival of the component ”.

“Until we ferment here, we will depend on the component they send us from Russia “, he said.

In this sense, he indicated that they estimated to be able to produce the active component in the country when the new production plant is completed and stressed that “in a year” they will be able to start manufacturing it on a scale industrial base for the world. “